
23 Mar 2022
Oxford BioMedica (Buy) - Strategic acquisition broadens the platform offering
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Oxford BioMedica (Buy) - Strategic acquisition broadens the platform offering
Oxford BioMedica plc (OXB:LON) | 652 -65.2 (-1.5%) | Mkt Cap: 783.1m
- Published:
23 Mar 2022 -
Author:
Miles Dixon -
Pages:
32 -